DUBLIN--(BUSINESS WIRE)--The "Glucose Biosensors Market Analysis, by Technology, by Product, by End Users and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The glucose biosensors market size is estimated to be USD 13,200 million in 2021 and is expected to witness a CAGR of 14.45% during the forecast period 2022-2029. The globally increasing self-monitoring device demand, modernizations in glucose biosensor technology, and a growing proportion of people worldwide developing diabetes are some of the primary market drivers. However, the strict regulatory framework and the high price of glucose biosensors are expected to restrain the market growth.
Regional Markets
In 2021, North America had the greatest share of the market due to the growing elderly population, diabetes's rising prevalence in the region, growing demand for remote and home monitoring, the increased incidence of diabetes brought on by lifestyle modifications, and improvements in technology.
However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing public understanding of the benefits of early diagnosis to increase patient survival rates, growing incomes, the accessibility of sophisticated glucose biosensors from a variety of vendors, and enhancements to healthcare facilities and payment procedures.
Segmentation: Glucose Biosensors Market Analysis Report 2021-2029
Technology (Revenue, USD Million)
- Optical Biosensors
- Electrochemical Biosensors
Product (Revenue, USD Million)
- Self-Monitoring Blood Glucose (SMBG)
- Continuous Glucose Monitoring (CGM)
End User (Revenue, USD Million)
- Home Care
- Hospitals
- Diagnostic Centres & Clinics
- Others
By Region (Revenue, USD Million)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Glucose Biosensors
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Glucose Biosensors Market
7. Market Analysis by Technology
8. Market Analysis by Product
9. Market Analysis by End User
10. Regional Market Analysis
11. North America Glucose Biosensors Market
12. Europe Glucose Biosensors Market
13. Asia Pacific Glucose Biosensors Market
14. Latin America Glucose Biosensors Market
15. MEA Glucose Biosensors Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion
19. Recommendations
Companies Mentioned
- Trividia Health (US)
- Sanofi (France)
- Nova Diabetes Care (USA)
- Lifescan (US)
- GlySens Incorporated (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Dexcom (US)
- Bayer (Germany)
- Ascenia Diabetes Care (Switzerland)
- Abbott Laboratories (US)
For more information about this report visit https://www.researchandmarkets.com/r/kl7etg
